Consumer health trends suggest a long-term shift away from companies reliant on seed oils and towards producers of traditional fats like butter and olive oil. The market for creatine is expanding beyond athletes to include cognitive health, signaling growth opportunities for supplement manufacturers. Within the broader longevity theme, consider companies developing at-home therapy devices like red light beds, which are gaining consumer traction. Established supplements such as Coenzyme Q10 offer a more direct way to invest in the growing mitochondrial health market. Finally, the increasing complexity of supplements points to future growth in the personalized health and diagnostic testing industry.

Investment Theme: Creatine & The Expanding Supplement Market

• The discussion highlights that the market and understanding of creatine are expanding significantly beyond its traditional use as a muscle-building supplement for athletes. • New research and discussion are focusing on its benefits for cognitive function. • A recent study was cited showing that 20 grams of creatine helped subjects perform better on brain puzzles and feel less tired during a full night of sleep deprivation. • It was also mentioned that 20 grams of creatine per day for six months was shown to double the rate of healing from traumatic brain injury. • The guest, Chris Masterjohn, suggests that almost every cell in the body uses the creatine system to distribute energy, implying a much broader range of health benefits than commonly understood. • Recommendation Context: It was suggested that anyone not eating 1-2 pounds of meat per day should probably supplement with creatine. Most vegans, in particular, would likely benefit from supplementation.

Takeaways

• The market for creatine appears poised for growth as its applications expand from athletic performance to cognitive enhancement, brain health, and general wellness. • Investors could look for opportunities in companies that manufacture or are major distributors of creatine and other well-researched supplements. • The broadening consumer base, including students, professionals, and older adults interested in cognitive health, could drive sustained demand.

Investment Theme: Mitochondrial Health & Longevity

• The core thesis of the discussion was that mitochondrial function is at the root of health, disease, and the aging process. This positions the entire "longevity" sector as a major area of interest. • Several specific products and therapies targeting mitochondria were discussed: * Red Light Therapy: Joe Rogan anecdotally reported that a red light bed reversed some of his macular degeneration. The guest explained that red and infrared light directly helps mitochondria produce more energy. This points to a growing consumer market for at-home health devices. * Coenzyme Q10 (CoQ10): Discussed as a key component in the mitochondrial energy production pathway. * The best food source is heart (beef, chicken, etc.), aligning with a "food first" approach. * Supplementation can be beneficial, with a "sweet spot" for the average person around 100-200 milligrams per day. * However, it was noted that needs are highly individual, with some people benefiting from much higher doses (e.g., a case study of a woman taking 700-800mg who regained her period after 10 years) while others experience negative side effects like insomnia or anxiety at lower doses. * Methylene Blue: Described as a high-risk, high-reward supplement that can create "detours" in mitochondrial pathways. * It can be very beneficial for individuals with specific mitochondrial "blockages" but can make function worse for healthy individuals. * The guest strongly advises against using it without specific mitochondrial testing to confirm it's needed.

Takeaways

• The longevity and mitochondrial health market is a significant long-term growth theme. • This includes a diverse range of companies, from those producing at-home therapy devices (like red light beds) to those in the specialty supplement space (CoQ10). • The discussion on Methylene Blue and the need for testing highlights a potential growth area for companies offering personalized health and diagnostic testing services. • Investors should be aware that this sector contains both established products (CoQ10) and highly speculative, controversial ones (Methylene Blue), requiring careful due diligence.

Investment Theme: Food Industry Shifts (Seed Oils vs. Traditional Fats)

• A significant portion of the conversation was dedicated to the negative health impacts of seed oils (e.g., corn, canola, grapeseed oil) and the benefits of traditional fats (e.g., butter, olive oil, animal fats). • Bearish Sentiment on Seed Oils: * The core argument is that seed oils make human tissues more vulnerable to damage over the long term, with negative effects on cancer and mortality rates only appearing in studies lasting 5-8 years or longer. * It was argued that short-term studies (e.g., 7-12 weeks) are often used to defend seed oils but miss the long-term damage. * The process of creating these oils often involves industrial solvents like hexane, which can remain in the final product. • Bullish Sentiment on Traditional Fats & "Nose-to-Tail" Eating: * The guest advocated for a "food first" approach, emphasizing eating a variety of animal proteins, including organ meats like liver and heart, to get essential nutrients. * This aligns with the growing consumer trend of "nose-to-tail" eating and seeking out high-quality, minimally processed animal products. * Fats like butter and olive oil were presented as healthier alternatives to processed seed oils.

Takeaways

• This discussion points to a durable, long-term consumer trend away from processed foods containing seed oils and towards whole foods and traditional fats. • Potential Headwinds: Companies in the packaged and processed food industries that are heavily reliant on cheap seed oils as a primary ingredient may face pressure as consumer awareness grows. • Potential Opportunities: * Companies that produce high-quality olive oil, avocado oil, and butter. * Niche but growing opportunities in the market for high-quality, grass-fed, and "nose-to-tail" animal products, including organ meats.